Michael T. Flavin

Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL.

Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million.

Cell Habitats, Inc. develops micro-sized regenerods for tissue repair. It engages in redefining the field of tissue repair by using biological and physical cues to prompt the body's own stem cells to restore normal function to damaged or diseased tissue. The firm also serves as a platform for the repair of bone, cartilage, muscle and nerve tissues. The company was founded by Brenda Russell, Tejal Desai and Paul Goldspink and is headquartered in Woodridge, IL.